Medifast (MED) Assets Average (2011 - 2026)

Medifast (MED) has 16 years of Assets Average data on file, last reported at $250.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 11.38% year-over-year to $250.0 million; the trailing twelve-month figure through Mar 2026 stood at $250.0 million (down 11.38% YoY), and the FY2025 full-year result was $266.1 million, down 10.42% from the prior year.
• Assets Average for Q1 2026 stood at $250.0 million, down from $258.1 million in the prior quarter.
• Across five years, Assets Average topped out at $409.9 million in Q1 2022 and bottomed at $250.0 million in Q1 2026.
• The 5-year median for Assets Average is $306.3 million (2024), against an average of $308.1 million.
• The widest annual swing landed in 2022, when Assets Average soared 36.06%; it then decreased 22.19% in 2023.
• A 5-year view of Assets Average shows it stood at $321.3 million in 2022, then retreated by 1.97% to $315.0 million in 2023, then declined by 8.65% to $287.7 million in 2024, then fell by 10.3% to $258.1 million in 2025, then decreased by 3.13% to $250.0 million in 2026.
• The last three Assets Average figures came in at $250.0 million (Q1 2026), $258.1 million (Q4 2025), and $268.8 million (Q3 2025), per Business Quant data.

Peer Comparison